Beyond the development of quality-of-life instruments: Where do we go from here?

被引：43

作者：

Levine, MN ^{[1
]}

Ganz, PA

机构：

[1] Henderson Gen Hosp, Hamilton, ON, Canada

[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2002.20.9.2215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2215 / 2216

页数：2

共 24 条

[1]

Aaronson N K, 1990, Oncology (Williston Park), V4, P59

[2]

Aaronson N K, 1988, Oncology (Williston Park), V2, P69

[3]

AARONSON NK, 1991, CANCER, V67, P844, DOI 10.1002/1097-0142(19910201)67:3+<844::AID-CNCR2820671416>3.0.CO

[4]

2-B

[5]

[Anonymous], 1996, J Clin Oncol, V14, P671

[6]

Bernhard J, 1998, STAT MED, V17, P517, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>3.0.CO

[7]

2-S

Browman, GP .

[9]

CELLA D F, 1988, Comprehensive Therapy, V14, P69

[10]

Cella D F, 1990, Oncology (Williston Park), V4, P29